- Capital Cube•5 days agoInternational Stem Cell Corp. :ISCO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 30, 2016
Categories: Yahoo Finance Get free summary analysis International Stem Cell Corp. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of International Stem Cell Corp. – Keryx Biopharmaceuticals, Inc., Opexa Therapeutics, Inc., Celgene Corporation, Anthera Pharmaceuticals, Inc., Chimerix, Inc. and Vericel Corporation (KERX-US, OPXA-US, CELG-US, ANTH-US, CMRX-US and ... Read more (Read more...)
- GlobeNewswire•19 days agoInternational Stem Cell Corporation Announces Operating Results for the Three and Nine-months ended September 30, 2016
CARLSBAD, Calif., Nov. 16, 2016-- International Stem Cell Corporation, a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business ...
- GlobeNewswire•25 days agoInternational Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson’s Disease at the Neuroscience 2016 Conference
CARLSBAD, Calif., Nov. 10, 2016-- International Stem Cell Corporation, a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today announced ...
ISCO : Summary for INTL STEM CELL COR COM STK USD0 - Yahoo Finance
International Stem Cell Corporation (ISCO)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.39|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|